Martínez-Aranda, Antonio <br/><br/>
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.  [electronic resource] 

 -  Oncotarget  Dec 2015 
 - 44254-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.5471  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Animals<br/>Area Under Curve<br/>Astrocytes--drug effects<br/>Biomarkers, Tumor--genetics<br/>Brain Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Ductal, Breast--drug therapy<br/>Cell Line, Tumor<br/>Cytokine TWEAK<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Likelihood Functions<br/>Membrane Glycoproteins--genetics<br/>Mice, Nude<br/>Middle Aged<br/>Precision Medicine<br/>Predictive Value of Tests<br/>Prognosis<br/>ROC Curve<br/>Receptors, Tumor Necrosis Factor--genetics<br/>Risk Assessment<br/>Risk Factors<br/>Spain<br/>TWEAK Receptor<br/>Thalidomide--therapeutic use<br/>Tissue Array Analysis<br/>Tumor Microenvironment<br/>Tumor Necrosis Factors--metabolism<br/>Xenograft Model Antitumor Assays<br/>Young Adult